Invest and Incubate Across the Value Chain
Our strategy is to invest in and incubate companies across the safe supply ecosystem to create a tightly woven fabric of synergies that generate short-term revenues to Safe Supply while also maximizing value accretion as our investee companies grow
As more jurisdictions move to decriminalize and legalize different psychoactive compounds, new opportunities will emerge.
As reform programs move forward, governments will need trusted sources of the different compounds to distribute to the programs.
Production of certain materials already occurs legally, such as the production of the coca plant in Peru. We will invest in companies importing / exporting such materials.
Science & Innovation
Schedule 1-3 compounds such as cannabis, psychedelics and others have been a source of many new medicines for approval and this trend will continue as other drugs are descheduled.
Education & Information
Governments are investing heavily in educating people and communities in how to safely prepare to safely rediscover this powerful compounds
Clinics and Distribution
The emerging market for psychoactive compounds will need new distribution pathways and clinical infrastructure to be delivered.
Many new applications in energy drinks, functional foods, pharmaceutical and nutraceutical are expected to emerge.
Testing & Analytics
Ensuring testing and analytical purity will be essential for new programs to operate effectively.
Benefits of Investing in Safe Supply
Safe Supply presents the smartest way to invest in the emerging safe supply ecosystem and the third wave of drug reform.